Page last updated: 2024-10-31

nafamostat and Cardiac Diseases

nafamostat has been researched along with Cardiac Diseases in 2 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Research Excerpts

ExcerptRelevanceReference
"Multiple hemorrhagic cerebral infarctions were recognized on a computed tomographic (CT) scan."1.39Left atrium ball thrombus in a patient with hemorrhagic cerebral infarction. ( Machida, D; Masuda, M; Matsuki, Y; Okamoto, H; Tokunaga, S; Yasuda, S, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yasuda, S1
Tokunaga, S1
Matsuki, Y1
Okamoto, H1
Machida, D1
Masuda, M1
Yamamura, M1
Miyamoto, T1
Yao, H1

Other Studies

2 other studies available for nafamostat and Cardiac Diseases

ArticleYear
Left atrium ball thrombus in a patient with hemorrhagic cerebral infarction.
    The Annals of thoracic surgery, 2013, Volume: 96, Issue:6

    Topics: Aged; Anticoagulants; Benzamidines; Cardiac Surgical Procedures; Cerebral Hemorrhage; Cerebral Infar

2013
Open heart surgery in a patient with autoimmune hemolytic anemia.
    The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 1999, Volume: 47, Issue:5

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Benzamidines; Betamethasone; Cardiopu

1999